miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes.
Aberrant micro RNA (miRNA) expression has been implicated in the pathogenesis of cancer. Recent studies have shown that the miR-17-92 cluster is overexpressed in many types of cancer. The oncogenic function of mature miRNAs encoded by the miR-17-92 cluster has been identified from the 5' arm of...
Main Authors: | Yong Xu, Fang Fang, Jiayou Zhang, Sajni Josson, William H St Clair, Daret K St Clair |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-12-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3008681?pdf=render |
Similar Items
-
Inverse relationship between PSA and IL-8 in prostate cancer: an insight into a NF-κB-mediated mechanism.
by: Yong Xu, et al.
Published: (2012-01-01) -
Radioresistance in Prostate Cancer: Focus on the Interplay between NF-κB and SOD
by: Sameera Kumar, et al.
Published: (2021-11-01) -
miR-17-3p Downregulates Mitochondrial Antioxidant Enzymes and Enhances the Radiosensitivity of Prostate Cancer Cells
by: Zhi Xu, et al.
Published: (2018-12-01) -
MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
by: Xiangyan Li, et al.
Published: (2013-01-01) -
Chemotherapy-Induced Tissue Injury: An Insight into the Role of Extracellular Vesicles-Mediated Oxidative Stress Responses
by: Chontida Yarana, et al.
Published: (2017-09-01)